Dr Herbert Opi
Senior Research Fellow
Working groups

Background
Following completion of his Bachelor of Science degree and a short stint as a research intern at the Kemri-Wellcome Trust Research Programme in Kilifi, Kenya, Herbert was awarded a Masters of Research (MRes) fellowship in 2007 to study at the University of Leeds. On completion of his masters, he re-joined the KEMRI-Wellcome Trust Research Programme to pursue a PhD in 2009 under the Supervision of Professor Tom Williams from KEMRI and Professor Alex Rowe from the University of Edinburgh, UK. The project mainly involved looking at the association between host genetic factors associated with the red blood cells and their association with protection against severe malaria in African children. Herbert successfully completed his PhD in 2013 and joined Professor James Beeson's group as a postdoctoral scientist. His project will focus on gaining new insights into the mechanisms of immunity to malaria and the pathogenesis of malaria disease particularly in pregnant women.
Qualifications
- 2013: PhD, The Open University/The University of Edinburgh/KEMRI-Wellcome Trust;
- 2008: MRes, The University of Leeds, UK;
- 2006: BSc, The University of Nairobi, Kenya
Appointments
- 2018: Fellow, Australian Centre for Research Excellence in Malaria Elimination (ACREME);
- 2016: Adjunct Lecturer, Department of Immunology Monash University
Awards
- 2019-2020: CASS Foundation Medicine Science Grant;
- 2018-2019: Australian Centre of Research Excellence in Malaria Elimination (ACREME) Seed Grant;
- 2018: CASS Foundation Travel Award;
- 2017: Harold Mitchell Foundation Postdoctoral Travel Fellowship;
- 2016: International Congress for Tropical Medicine and Malaria Travel award, Brisbane, Australia;
- 2015: Elsevier Best Postdoctoral Poster Presentation, Malaria in Melbourne Conference, Australia;
- 2012: Early Career Research Poster Prize, Molecular Approaches to Malaria, Lorne, Australia;
- 2012: Molecular Approaches to Malaria 2012 Meeting Travel Scholarship, Lorne, Australia;
- 2011: British Society of Parasitology 2011 Spring Meeting Travel Award, Nottingham, UK;
- 2007-2008: Marie Curie Early Stage Training Masters Fellowship, University of Leeds, UK
Burnet publications
View 3 morePotent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages
Research Square (Research Square)
Christopher L. King et al
Complement detection on trophozoite stage Plasmodium falciparumparasites using flow cytometry or Western blot
Research Square (Research Square)
Herbert Opi, James G. Beeson
A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites
Research Square (Research Square)
Michael Foley et al
Current projects
View 2 moreHealthy Mothers, Healthy Babies (HMHB)
A collaborative research program aimed at providing life-saving health care for women and children in Papua New Guinea.

Vaccines against malaria caused by Plasmodium falciparum and P. vivax
The project identifies and prioritises candidate antigens for vaccine development.

Developing next-generation mRNA vaccines for malaria
Vaccination is a highly effective strategy to protect populations against infectious diseases. Highly protective and long-lasting vaccines are needed to reduce the global burden of malaria and enable elimination.